Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY4 known ✓ | P51582 | 10/20 | 0.72 |
| ▸ | P2RY12 known ✓ | Q9H244 | 8/20 | 0.72 |
| ▸ | P2RY2 known ✓ | P41231 | 7/20 | 0.72 |
| ▸ | P2RY1 known ✓ | P47900 | 3/20 | 0.72 |
| ▸ | P2RY6 known ✓ | Q15077 | 2/20 | 0.72 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.68 |
| ▸ | CDK2 | P24941 | 3/20 | 0.72 |
| ▸ | MET | P08581 | 2/20 | 0.69 |
| ▸ | HGF | P14210 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | NSD2 | O96028 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11343912 | 0.86 | P2RY4 (0.69) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL11651457 | 0.84 | GNG2 (0.77) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL3032350 | 0.84 | P2RY4 (0.80) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| Acid Blue 25 SCHEMBL29355038 | 0.84 | P2RY4 (1.00) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| Acid Blue 25 SCHEMBL790822 | 0.84 | P2RY4 (1.00) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL11348178 | 0.83 | GNG2 (0.75) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL3033638 | 0.83 | P2RY12 (0.80) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL7534353 | 0.83 | CDK2 (0.84) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL791688 | 0.82 | P2RY4 (1.00) | P2RY4P2RY12P2RY2CDK2P2RY1 | |
| SCHEMBL3030976 | 0.82 | P2RY4 (1.00) | P2RY4P2RY12P2RY2CDK2P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119023529-A | Physical and data combined super-resolution dynamic digital core intelligent reconstruction method | 中国石油大学(华东) | 2024-11-26 | — | — | CN | claimed |
| CN-118351191-A | Improved projector calibration method | 天翼云科技有限公司 | 2024-07-16 | — | — | CN | claimed |
| EP-3490994-B1 | SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | APTINYX INC (US) | 2024-02-07 | — | — | EP | claimed |
| CN-114252485-B | Electrochemical aptamer sensor for detecting mycobacterium tuberculosis MPT64 and detection method thereof | 重庆医科大学 | 2023-06-06 | — | — | CN | claimed |
| EP-2934581-B1 | INFLUENZA VIRUS VACCINES AND USES THEREOF | ICAHN SCHOOL MED MOUNT SINAI (US) | 2022-09-14 | — | — | EP | claimed |
| CN-114252485-A | Electrochemical aptamer sensor for detecting mycobacterium tuberculosis MPT64 and detection method thereof | 重庆医科大学 | 2022-03-29 | — | — | CN | claimed |
| EP-4748447-A2 | INFLUENZA VIRUS VACCINES AND USES THEREOF | Icahn School of Medicine at Mount Sinai (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4746906-A1 | IMMUNOGENIC COMPOSITIONS CONTAINING INACTIVATED INFLUENZA A VIRUS AND CPG OLIGONUCLEOTIDE ADJUVANT AND USES THEREOF | Icahn School of Medicine at Mount Sinai (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-4742765-A2 | METHODS AND APPARATUSES FOR SYNCHRONIZATION SIGNAL TRANSMISSION | NEC Corporation (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-12627497-B2 | Apparatus and method for decrypting an encrypted bit sequence | INFINEON TECHNOLOGIES AG (DE) | 2026-05-12 | — | — | US | disclosed |
| US-20260091589-A1 | Liquid Ejecting Head And Liquid Ejecting Apparatus | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260091603-A1 | Head Unit And Liquid Ejecting Apparatus | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| US-20260091602-A1 | Liquid Ejecting Head And Liquid Ejecting Apparatus | SEIKO EPSON CORP (JP) | 2026-04-02 | — | — | US | disclosed |
| CN-114501607-A | Method and apparatus for synchronization signal transmission | 日本电气株式会社 | 2022-05-13 | — | — | CN | disclosed |
| US-20220098211-A1 | SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | APTINYX INC. | 2022-03-31 | — | — | US | disclosed |
| CN-114252485-A | Electrochemical aptamer sensor for detecting mycobacterium tuberculosis MPT64 and detection method thereof | 重庆医科大学 | 2022-03-29 | — | — | CN | disclosed |
| CN-114252485-A | Electrochemical aptamer sensor for detecting mycobacterium tuberculosis MPT64 and detection method thereof | 重庆医科大学 | 2022-03-29 | — | — | CN | disclosed |
| US-11283608-B2 | Executing a cryptographic operation | INFINEON TECHNOLOGIES AG (DE) | 2022-03-22 | — | — | US | disclosed |
| US-11236429-B2 | Production of chemical products using electrochemical flow systems and slug flow and associated methods | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-02-01 | — | — | US | disclosed |
| US-4294769-A | Process for the preparation of 1,4-diamino-2,3-dicyano-anthraquinones | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091589-A1 | Liquid Ejecting Head And Liquid Ejecting Apparatus | NUP160, MIA3, ELAVL1 | P2RY4 3241/4885P2RY12 3250/4885P2RY2 2966/4885 |
| US-20260091602-A1 | Liquid Ejecting Head And Liquid Ejecting Apparatus | NUTF2, LSM14A, ZMYND8 | P2RY4 3376/4885P2RY12 3809/4885P2RY2 3455/4885 |
| US-20220098211-A1 | SPIRO-LACTAM AND BIS-SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF | GRIN1, GRIN2A, GRIN2C | P2RY4 1779/4885P2RY12 555/4885P2RY2 2074/4885 |
| US-20260091603-A1 | Head Unit And Liquid Ejecting Apparatus | L1CAM, AUP1, STUB1 | P2RY4 3820/4885P2RY12 4071/4885P2RY2 3541/4885 |
| US-12627497-B2 | Apparatus and method for decrypting an encrypted bit sequence | TES, XPOT, DDX41 | P2RY4 259/4885P2RY12 602/4885P2RY2 177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.